Castle Biosciences, Inc. · 2 hours ago
Reimbursement, Payer Configuration Specialist (FWD)
Castle Biosciences, Inc. is a growing company recognized for its workplace excellence. They are seeking a full-time Reimbursement Payer Configuration Specialist who will be responsible for configuring and maintaining insurance plan information, ensuring compliance with payer guidelines, and supporting clean claim submissions.
BiotechnologyHealth CareHealth Diagnostics
Responsibilities
Configures and maintains insurance plan information within the Telcor billing system
The Payer Configuration Specialist is responsible for researching payer requirements and accurately setting up insurance plans within the billing system
This role ensures compliance with payer guidelines and supports clean claim submission by maintaining up-to-date payer information and maintaining the integrity of the insurance plans within the Telcor system
Qualification
Required
Bachelor's degree in education, business, or related field, required and/or equivalent combination of experience and education
3 years + experience in application configuration, business systems analysis, or workflow automation
Strong understanding of system configuration, business process automation and integration best practices
Working knowledge and experience researching insurance plan requirements for prior authorization, claims, and appeals
Moderate to advanced excel skills (Pivot tables; v-look up)
Typing speed of 35 or more words per minute, with 90% or greater accuracy
All candidates must be legally authorized to work in the United States. Currently, Castle Biosciences does not sponsor H-1B visas, OPT, or employment-related visas
Benefits
20 Accrued PTO Days Annually
10 Paid Holidays
401K with 100% Company Match up to 6%
3 Health Care Plan Options + Company HSA Contribution
Company Stock Grant Upon Hire
Company
Castle Biosciences, Inc.
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care.
Funding
Current Stage
Public CompanyTotal Funding
$427.33MKey Investors
BrightEdge FundIndustry VenturesHealthQuest Capital
2020-12-15Post Ipo Equity· $266.8M
2020-06-24Post Ipo Equity· $74M
2019-07-24Series Unknown
Recent News
News Powered by Cision
2026-01-22
GlobeNewswire
2026-01-12
Company data provided by crunchbase